CD4 and nonpapillary renal cell carcinoma: (5) The combination treatment of EGCG with sunitinib significantly decreased the frequency of CD4+, CD25+, CD127low, FOXP3+, Treg in the PBMC of the ccRCC patients compared to the group without treatment